1. Home
  2. IMMP vs AREN Comparison

IMMP vs AREN Comparison

Compare IMMP & AREN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • AREN
  • Stock Information
  • Founded
  • IMMP 1987
  • AREN 2016
  • Country
  • IMMP Australia
  • AREN United States
  • Employees
  • IMMP N/A
  • AREN N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • AREN Medical/Dental Instruments
  • Sector
  • IMMP Health Care
  • AREN Health Care
  • Exchange
  • IMMP Nasdaq
  • AREN Nasdaq
  • Market Cap
  • IMMP 251.8M
  • AREN 233.1M
  • IPO Year
  • IMMP N/A
  • AREN N/A
  • Fundamental
  • Price
  • IMMP $1.93
  • AREN $5.61
  • Analyst Decision
  • IMMP Buy
  • AREN Strong Buy
  • Analyst Count
  • IMMP 1
  • AREN 1
  • Target Price
  • IMMP $7.00
  • AREN $12.00
  • AVG Volume (30 Days)
  • IMMP 208.1K
  • AREN 214.5K
  • Earning Date
  • IMMP 10-10-2025
  • AREN 11-13-2025
  • Dividend Yield
  • IMMP N/A
  • AREN N/A
  • EPS Growth
  • IMMP N/A
  • AREN N/A
  • EPS
  • IMMP N/A
  • AREN 2.74
  • Revenue
  • IMMP $3,306,742.00
  • AREN $146,610,000.00
  • Revenue This Year
  • IMMP $16.82
  • AREN $29.48
  • Revenue Next Year
  • IMMP N/A
  • AREN $11.72
  • P/E Ratio
  • IMMP N/A
  • AREN $8.90
  • Revenue Growth
  • IMMP 31.28
  • AREN 6.81
  • 52 Week Low
  • IMMP $1.32
  • AREN $0.56
  • 52 Week High
  • IMMP $2.71
  • AREN $10.05
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 45.60
  • AREN N/A
  • Support Level
  • IMMP $1.88
  • AREN N/A
  • Resistance Level
  • IMMP $2.08
  • AREN N/A
  • Average True Range (ATR)
  • IMMP 0.10
  • AREN 0.00
  • MACD
  • IMMP -0.03
  • AREN 0.00
  • Stochastic Oscillator
  • IMMP 4.97
  • AREN 0.00

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

Share on Social Networks: